These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32472706)

  • 1. The long-standing history of Corynebacterium parvum, immunity, and viruses.
    Palmieri B; Vadalà M; Roncati L; Garelli A; Scandone F; Bondi M; Cermelli C
    J Med Virol; 2020 Nov; 92(11):2429-2439. PubMed ID: 32472706
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Palmieri B; Vadalà M
    J Interferon Cytokine Res; 2021 Mar; 41(3):132-136. PubMed ID: 33750214
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.
    Cohen DA; Bubel HC
    J Reticuloendothel Soc; 1983 Jan; 33(1):35-46. PubMed ID: 6300395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the immune-modulators Parapoxvirus ovis and Propionibacterium acnes for the prevention of respiratory disease and other infections in the horse.
    Paillot R
    Vet Immunol Immunopathol; 2013 May; 153(1-2):1-9. PubMed ID: 23481655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.
    Glasgow LA; Fischbach J; Bryant SM; Kern ER
    J Infect Dis; 1977 May; 135(5):763-70. PubMed ID: 192811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of Corynebacterium parvum on various viral infections in the mouse].
    Geniteau M; Quero AM; German A
    Ann Pharm Fr; 1977; 35(5-6):181-7. PubMed ID: 900789
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiviral effects of Corynebacterium parvum and its effect on the interferon system in mice.
    Kirchner H; Chmielarczyk W; Storch E; Schindler L
    Behring Inst Mitt; 1984 May; (74):183-8. PubMed ID: 6206840
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced resistance against Junin virus infection induced by Corynebacterium parvum.
    Budzko DB; Casals J; Waksman BH
    Infect Immun; 1978 Mar; 19(3):893-7. PubMed ID: 205508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopotentiation of cell-mediated hypersensitivity by Corynebacterium parvum (Propionibacterium acnes).
    Maguire HC; Cipriano D
    Int Arch Allergy Appl Immunol; 1983; 70(1):34-9. PubMed ID: 6848475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and immunological studies on the cell walls of Propionibacterium acnes strain C7 and Corynebacterium parvum ATCC 11829.
    Azuma I; Sugimura K; Taniyama T; Aladin A; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):265-75. PubMed ID: 811835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria.
    Ojo E
    Cell Immunol; 1979 Jun; 45(1):182-7. PubMed ID: 455483
    [No Abstract]   [Full Text] [Related]  

  • 12. The protective effect of pretreatment with killed Corynebacterium parvum against acute babesiosis in calves.
    Corrier DE; Wagner GG
    Vet Parasitol; 1984 Aug; 15(2):165-8. PubMed ID: 6541833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Corynebacterium parvum in the activation of peritoneal macrophages. 1. Association between intracellular C. parvum and cytotoxic macrophages.
    Chapes SK; Haskill S
    Cell Immunol; 1982 Jun; 70(1):65-75. PubMed ID: 7116464
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-specific immunization against bovine tropical theileriosis (Theileria annulata) using killed Corynebacterium parvum.
    Manickam R; Dhar S; Singh RP
    Vet Parasitol; 1983 Sep; 13(2):115-9. PubMed ID: 6685397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Corynebacterium parvum on the immune response in guinea pigs. I. Mode of enhancement of the anamnestic response and development of delayted hypersensitivity after treatment with Corynebacterium parvum].
    Halpern B; Gauthier-Rahman S; Besluau D
    C R Seances Soc Biol Fil; 1977; 171(6):1202-8. PubMed ID: 148948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Corynebacterium parvum after intraperitoneal injection in hamsters.
    Duthu A; Alexandrov I; Le Goffic N; De Vaux St Cyr C
    Dev Comp Immunol; 1984; 8(1):231-6. PubMed ID: 6233193
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance to infections in mice with defects in the activities of mononuclear phagocytes and natural killer cells: effects of immunomodulators in beige mice and 89Sr-treated mice.
    Morahan PS; Coleman PH; Morse SS; Volkman A
    Infect Immun; 1982 Sep; 37(3):1079-85. PubMed ID: 6290389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer model.
    Knapp RC; Berkowitz RS
    Am J Obstet Gynecol; 1977 Aug; 128(7):782-6. PubMed ID: 560124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by Corynebacterium parvum. 1. Variable effects on anti-sheep erythrocyte antibody responses.
    Ghaffar A; Sigel MM
    Immunology; 1978 Nov; 35(5):685-93. PubMed ID: 363603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.